204 related articles for article (PubMed ID: 7893945)
1. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
Beck-Sickinger AG; Jung G
Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
[TBL] [Abstract][Full Text] [Related]
2. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
[TBL] [Abstract][Full Text] [Related]
3. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.
Michel MC; Gaida W; Beck-Sickinger AG; Wieland HA; Doods H; Dürr H; Jung G; Schnorrenberg G
Mol Pharmacol; 1992 Oct; 42(4):642-8. PubMed ID: 1331755
[TBL] [Abstract][Full Text] [Related]
5. Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations.
Beck-Sickinger AG; Wieland HA; Wittneben H; Willim KD; Rudolf K; Jung G
Eur J Biochem; 1994 Nov; 225(3):947-58. PubMed ID: 7957231
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
Cabrele C; Beck-Sickinger AG
J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
[TBL] [Abstract][Full Text] [Related]
7. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
8. Expression cloning of a human brain neuropeptide Y Y2 receptor.
Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
10. Alpha-helical small molecular size analogues of neuropeptide Y: structure-activity relationships.
Jung G; Beck-Sickinger AG; Dürr H; Gaida W; Schnorrenberg G
Biopolymers; 1991 May; 31(6):613-9. PubMed ID: 1657233
[TBL] [Abstract][Full Text] [Related]
11. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
[TBL] [Abstract][Full Text] [Related]
12. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions.
Kirby DA; Boublik JH; Rivier JE
J Med Chem; 1993 Nov; 36(24):3802-8. PubMed ID: 8254609
[TBL] [Abstract][Full Text] [Related]
14. Analogues of neuropeptide Y containing beta-aminocyclopropane carboxylic acids are the shortest linear peptides that are selective for the Y1 receptor.
Koglin N; Zorn C; Beumer R; Cabrele C; Bubert C; Sewald N; Reiser O; Beck-Sickinger AG
Angew Chem Int Ed Engl; 2003 Jan; 42(2):202-5. PubMed ID: 12532350
[No Abstract] [Full Text] [Related]
15. Conformational analysis of neuropeptide Y segments by CD, NMR spectroscopy and restrained molecular dynamics.
Gurrath M; Bisello A; Bottazzo K; Chung CW; Mammi S; Peggion E
J Pept Sci; 1996; 2(3):176-93. PubMed ID: 9231326
[TBL] [Abstract][Full Text] [Related]
16. Identification of high-potency neuropeptide Y analogues through systematic lactamization.
Kirby DA; Britton KT; Aubert ML; Rivier JE
J Med Chem; 1997 Jan; 40(2):210-5. PubMed ID: 9003519
[TBL] [Abstract][Full Text] [Related]
17. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of alpha-helix in C-terminal fragments of neuropeptide Y.
Yumoto N; Murase S; Hattori T; Yamamoto H; Tatsu Y; Yoshikawa S
Biochem Biophys Res Commun; 1993 Nov; 196(3):1490-5. PubMed ID: 8250906
[TBL] [Abstract][Full Text] [Related]
19. Modulation of neuropeptide Y receptors for the treatment of obesity.
Sato N; Ogino Y; Mashiko S; Ando M
Expert Opin Ther Pat; 2009 Oct; 19(10):1401-15. PubMed ID: 19743896
[TBL] [Abstract][Full Text] [Related]
20. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment.
Doughty MB; Hu L
Biopolymers; 1993 Aug; 33(8):1195-206. PubMed ID: 8364154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
